TEL AVIV, Israel–(BUSINESS WIRE)–Medorion (https://medorion.com/), a SaaS-solution provider enabling healthcare organizations to create, manage, and measure personalized health persuasion plans, wins Pfizer’s Vaccines Global Innovation Challenge, which was launched to find innovative approaches that address both patient education and access to vaccination.

Having developed the world’s preferred COVID-19 vaccine shot, Pfizer has proved itself a dedicated player in its mission of ensuring medical centers worldwide have access to life-saving vaccines, while patients have easy access to information and education on their importance. Higher risk groups require effective, non abrasive communications between medical authorities, health plans, providers administrators, medical personnel, and various information channels in order to safely remain inline with crucial vaccine guidelines and protect themselves. Moreover, communications that address personal barriers are much more likely to influence decision-making and much less likely to create abrasion, which could prove instrumental in, for instance, achieving better vaccination outcomes.

As part of the Vaccines Global Innovation Challenge, Pfizer challenged the tech medical sector to firstly explore innovation in Information and Education, particularly for adolescents and adult populations that could potentially benefit from staying up-to-date on various recommended vaccines. Secondly, the challenge required participants to identify the means by which appropriate patients gain access to recommended vaccines. Each finalist was given the opportunity to pitch their presentation in front of a live audience at the Frontiers Health conference, which was accompanied by spirited panel discussions.